<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
rmed-s8.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;letter-spacing:-0.15pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As filed with the Securities and Exchange Commission on February 7, 2023</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="border-bottom:Solid 1.5pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;font-size:10pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:61.54%;">Registration Statement No. 333-</p>
<p style="border-bottom:Solid 1.5pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.15pt;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">    </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.15pt;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.15pt;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C.&nbsp;&nbsp;20549</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.15pt;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM S-8</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.15pt;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.15pt;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.15pt;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RA MEDICAL SYSTEMS, INC.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:50%;"></td>
<td style="width:50%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Delaware</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">38-3661826</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">incorporation or organization)</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:8pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1670 Highway 160 West, Suite 205</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fort Mill, SC 29708</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of Principal Executive Offices) (Zip Code)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock Options Granted under the</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Catheter Precision, Inc. Amended and Restated 2009 Equity Incentive Plan </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">and </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Notice of Non-Plan Stock Option Award and Stock Option Award Terms </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Full title of the plan)</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:8pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Jonathan Will McGuire</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ra Medical Systems Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1670 Highway 160 West, Suite 205</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fort Mill, SC 29708</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(973) 691-2000</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Name and address of agent for service) (Telephone number, including area code, of agent for service)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Copies to:</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">B. Joseph Alley, Jr., Esq.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Arnall Golden Gregory LLP</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">171 17<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Street NW, Suite 2100</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Atlanta, Georgia 30363</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(404) 873-8500</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Large accelerated filer</font><font style="margin-left:36pt;"> </font><font style="margin-left:36pt;"></font><font style="font-family:Segoe UI Symbol;">&#9744;</font><font style="margin-left:36pt;">&nbsp;&nbsp;</font><font style="margin-left:36pt;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accelerated filer</font><font style="margin-left:36pt;"> </font><font style="margin-left:36pt;"></font><font style="margin-left:36pt;"></font><font style="margin-left:36pt;"></font><font style="font-family:Segoe UI Symbol;">&#9744;</font></p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-accelerated filer<font style="margin-left:36pt;"> </font><font style="font-family:Segoe UI Symbol;">&#9746;</font><font style="margin-left:36pt;">&nbsp;&nbsp;</font>Smaller reporting company<font style="margin-left:36pt;"> </font><font style="font-family:Segoe UI Symbol;">&#9746;</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <font style="margin-left:36pt;">&nbsp;&nbsp;</font>Emerging growth company<font style="margin-left:36pt;"> </font><font style="font-family:Segoe UI Symbol;">&#9746;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act.&#160;<font style="font-family:'Times New Roman';color:#000000;"><font style="font-size:10pt;font-family:'Times New Roman'">&#9744;</font></font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART I</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information specified in Items 1 and 2 of Part I of Form S-8 is omitted from this Registration Statement on Form S-8 (the &#8220;Registration Statement&#8221;) in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and the introductory note to Part I of Form S-8. The documents containing the information specified in Part I of Form S-8 will be sent or given to the holders of stock options to purchase up to 753,699 shares of Ra Medical Systems, Inc. common stock granted under the Catheter Precision, Inc. Amended and Restated 2009 Equity Incentive Plan (the &#8220;Plan&#8221;) and a Notice of Non-Plan Stock Option Award and Stock Option Award Terms that have been assumed by Ra Medical Systems, Inc. in connection with its acquisition by merger of Catheter Precision, Inc., and that are covered by this Registration Statement, as required by Rule 428(b)(1) under the Securities Act. Such documents are not required to be, and are not, filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) either as part of this Registration Statement or as a prospectus or prospectus supplement pursuant to Rule 424 under the Securities Act. </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART II</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Item 3.</font><font style="text-decoration:underline;margin-left:0pt;">Incorporation of Documents by Reference</font>.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">The following documents filed with the SEC by Ra Medical Systems, Inc. (the &#8220;Registrant&#8221; or the &#8220;Company&#8221;) are hereby incorporated by reference herein:</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">a)</font><font style="font-size:12pt;margin-left:36pt;color:#000000;"></font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022011555/rmed-10k_20211231.htm"><font style="text-decoration:underline;color:#000000;">our Annual Report on Form 10-K (excluding Item 15) for the year ended December 31, 2021, filed with the SEC on March 24, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">; </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">b)</font><font style="font-size:12pt;margin-left:36pt;color:#000000;"></font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022025660/rmed-10ka_20211231.htm"><font style="text-decoration:underline;color:#000000;">our Annual Report on Form 10-K/A for the year ended December 31, 2021, filed with the SEC on July 13, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">c)</font><font style="font-size:12pt;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">the information specifically incorporated by reference in our Annual Report on Form 10-K for the year ended December 31, 2021, from our Definitive Proxy Statement related to our 2022 Annual Meeting of Stockholders, filed with the SEC on </font><a href="http://www.sec.gov/Archives/edgar/data/1716621/000156459022014994/rmed-def14a_20220603.htm"><font style="text-decoration:underline;color:#000000;">April 21, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">d)</font><font style="font-size:12pt;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">our Quarterly Reports on Form 10-Q for the quarterly period ended March 31, 2022, filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022020432/rmed-10q_20220331.htm"><font style="text-decoration:underline;color:#000000;">May 16, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">; for the quarterly period ended June 30, 2022, filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022020432/rmed-10q_20220331.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022029521/rmed-10q_20220630.htm"><font style="text-decoration:underline;color:#000000;">August 15, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">; and for the quarterly period ended September 30, 2022, filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022020432/rmed-10q_20220331.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022029521/rmed-10q_20220630.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022037665/rmed-10q_20220930.htm"><font style="text-decoration:underline;color:#000000;">November 14, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">e)</font><font style="font-size:12pt;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">our Current Reports on Form 8-K and amendments thereto filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><font style="text-decoration:underline;color:#000000;">January 24, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><font style="text-decoration:underline;color:#000000;">February 9, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><font style="text-decoration:underline;color:#000000;">April 20, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><font style="text-decoration:underline;color:#000000;">May 16, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (excluding information furnished thereunder), </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><font style="text-decoration:underline;color:#000000;">June 6, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><font style="text-decoration:underline;color:#000000;">July 8, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (excluding information furnished thereunder), </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><font style="text-decoration:underline;color:#000000;">July 18, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><font style="text-decoration:underline;color:#000000;">July 22, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as amended on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><font style="text-decoration:underline;color:#000000;">September 2, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><font style="text-decoration:underline;color:#000000;">August 12, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><font style="text-decoration:underline;color:#000000;">August 17, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><font style="text-decoration:underline;color:#000000;">September 2, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><font style="text-decoration:underline;color:#000000;">September 12, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032010/rmed-8k_20220920.htm"><font style="text-decoration:underline;color:#000000;">September 20, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032010/rmed-8k_20220920.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032327/rmed-8k_20220927.htm"><font style="text-decoration:underline;color:#000000;">September 27, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032010/rmed-8k_20220920.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032327/rmed-8k_20220927.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032641/rmed-8k_20220929.htm"><font style="text-decoration:underline;color:#000000;">September 29, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032010/rmed-8k_20220920.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032327/rmed-8k_20220927.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032641/rmed-8k_20220929.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022033267/rmed-8k_20221004.htm"><font style="text-decoration:underline;color:#000000;">October 4, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032010/rmed-8k_20220920.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032327/rmed-8k_20220927.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032641/rmed-8k_20220929.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022033267/rmed-8k_20221004.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022034366/rmed-8k_20221017.htm"><font style="text-decoration:underline;color:#000000;">October 17, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032010/rmed-8k_20220920.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032327/rmed-8k_20220927.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032641/rmed-8k_20220929.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022033267/rmed-8k_20221004.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022034366/rmed-8k_20221017.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022034765/rmed-8k_20221020.htm"><font style="text-decoration:underline;color:#000000;">October 20, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032010/rmed-8k_20220920.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032327/rmed-8k_20220927.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032641/rmed-8k_20220929.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022033267/rmed-8k_20221004.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022034366/rmed-8k_20221017.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022034765/rmed-8k_20221020.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022036622/rmed-8k_20221028.htm"><font style="text-decoration:underline;color:#000000;">November 3, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032010/rmed-8k_20220920.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032327/rmed-8k_20220927.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032641/rmed-8k_20220929.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022033267/rmed-8k_20221004.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022034366/rmed-8k_20221017.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022034765/rmed-8k_20221020.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022036622/rmed-8k_20221028.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022038507/rmed-8k_20221129.htm"><font style="text-decoration:underline;color:#000000;">November 29, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032010/rmed-8k_20220920.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032327/rmed-8k_20220927.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032641/rmed-8k_20220929.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022033267/rmed-8k_20221004.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022034366/rmed-8k_20221017.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022034765/rmed-8k_20221020.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022036622/rmed-8k_20221028.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022038507/rmed-8k_20221129.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022038854/rmed-8k_20221201.htm"><font style="text-decoration:underline;color:#000000;">December 2, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032010/rmed-8k_20220920.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032327/rmed-8k_20220927.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032641/rmed-8k_20220929.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022033267/rmed-8k_20221004.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022034366/rmed-8k_20221017.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022034765/rmed-8k_20221020.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022036622/rmed-8k_20221028.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022038507/rmed-8k_20221129.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022038854/rmed-8k_20221201.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022039348/rmed-8k_20221214.htm"><font style="text-decoration:underline;color:#000000;">December 15, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032010/rmed-8k_20220920.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032327/rmed-8k_20220927.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032641/rmed-8k_20220929.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022033267/rmed-8k_20221004.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022034366/rmed-8k_20221017.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022034765/rmed-8k_20221020.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022036622/rmed-8k_20221028.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022038507/rmed-8k_20221129.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022038854/rmed-8k_20221201.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022039348/rmed-8k_20221214.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459023000429/rmed-8k_20230109.htm"><font style="text-decoration:underline;color:#000000;">January 13, 2023</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as amended </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022002008/rmed-8k_20220118.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022004272/rmed-8k_20220204.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022014909/rmed-8k_20220415.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022020412/rmed-8k_20220510.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022022586/rmed-8k_20220603.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025521/rmed-8k_20220708.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022025910/rmed-8k_20220714.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022026217/rmed-8k_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030981/rmed-8ka_20220722.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029307/rmed-8k_20220810.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022029707/rmed-8k_20220816.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022030972/rmed-8k_20220831.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022031424/rmed-8k_20220909.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032010/rmed-8k_20220920.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032327/rmed-8k_20220927.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022032641/rmed-8k_20220929.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022033267/rmed-8k_20221004.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716621/000156459022034366/rmed-8k_20221017.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022034765/rmed-8k_20221020.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022036622/rmed-8k_20221028.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022038507/rmed-8k_20221129.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022038854/rmed-8k_20221201.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459022039348/rmed-8k_20221214.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459023000429/rmed-8k_20230109.htm"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1716621/000156459023000558/rmed-8ka_20230109.htm"><font style="text-decoration:underline;color:#000000;">January 19, 2023</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">; and</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">f)</font><font style="font-size:12pt;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">our Definitive Proxy Statement related to our September 20, 2022 Special Meeting of Stockholders, filed with the SEC on </font><a href="http://www.sec.gov/Archives/edgar/data/1716621/000156459022030319/rmed-def14a_20220920.htm"><font style="text-decoration:underline;color:#000000;">August 29, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">g)</font><font style="font-size:12pt;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">our revised Preliminary Proxy Statement filed with the SEC on </font><a href="http://www.sec.gov/Archives/edgar/data/1716621/000119312522277180/d375656dprer14a.htm"><font style="text-decoration:underline;color:#000000;">November 4, 2022</font></a><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">; and</font></p>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:11.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">h)</font><font style="font-size:12pt;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">the description of our common stock contained in our Registration Statement on Form 8-A that we filed with the SEC on </font><a href="http://www.sec.gov/Archives/edgar/data/1716621/000095012320012698/rmed-8a_20201217.htm"><font style="text-decoration:underline;color:#000000;">December 17, 2020</font></a><font style="color:#000000;">, including any amendment or report filed for the purpose of updating such description.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">All documents that we file with the SEC pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), after the filing of this Registration Statement on Form&#160;S&#8209;8 (and prior to the filing of any post&#8209;effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which de-registers all securities remaining unsold), shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of such reports and documents.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">Any statement contained in this Registration Statement, in an amendment hereto or in a document incorporated by reference herein shall be deemed modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein, in any subsequently filed supplement to this Registration Statement or any document that is also incorporated by reference herein modifies or supersedes such statement.&#160; Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Item 4.</font><font style="text-decoration:underline;margin-left:36pt;">Description of Securities</font>.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable. </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Item 5.&nbsp;&nbsp;Interests of Named Experts and Counsel.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Item 6.&nbsp;&nbsp;Indemnification of Directors and Officers</font>.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that eliminate the personal liability of our directors and executive officers for monetary damages for breach of their fiduciary duties as directors or officers.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section&#160;145 of the Delaware General Corporation Law provides that a corporation may indemnify any person made a party to an action by reason of the fact that he or she was a director, executive officer, employee or agent of the corporation or is or was serving at the request of a corporation against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of an action by or in right of the corporation, no indemnification may generally be made in respect of any claim as to which such person is adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, as permitted by Section 145 of the Delaware General Corporation Law, our amended and restated certificate of incorporation and amended and restated bylaws will provide that:</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We shall indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Delaware law. Delaware law provides </p>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:11.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of us and, with respect to any criminal proceeding, had no reasonable cause to believe such person&#8217;s conduct was unlawful.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are required to advance expenses, as incurred, to its directors and officers in connection with defending a proceeding, except that such director or officer shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We will not be obligated pursuant to the amended and restated bylaws to indemnify a person with respect to proceedings initiated by that person, except with respect to proceedings authorized by our board of directors or brought to enforce a right to indemnification.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The rights conferred in the amended and restated certificate of incorporation and amended and restated bylaws are not exclusive, and we are authorized to enter into indemnification agreements with its directors, officers, employees, and agents and to obtain insurance to indemnify such persons.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may not retroactively amend the bylaw provisions to reduce our indemnification obligations to directors, officers, employees, and agents.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have entered into indemnification agreements with our directors and executive officers that provide the maximum indemnity allowed to directors and executive officers by Section&#160;145 of the Delaware General Corporation Law and also to provide for certain additional procedural protections, in addition to the indemnification provided for in our amended and restated certificate of incorporation and bylaws.&nbsp;&nbsp;We also intend to enter into indemnification agreements with any new directors and executive officers in the future.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have purchased and currently intend to maintain insurance on behalf of each and any person who is or was a director or officer of us against any loss arising from any claim asserted against him or her and incurred by him or her in any such capacity, subject to certain exclusions.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reference is made to Item 9(c) for our undertakings with respect to indemnification for liabilities arising under the Securities Act.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Item 7.&nbsp;&nbsp;Exemption from Registration Claimed</font>.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">Not applicable. </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Item 8.</font><font style="text-decoration:underline;margin-left:36pt;">Exhibits.</font>&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:3.08%;width:96.15%;">
<tr>
<td style="width:23.08%;"></td>
<td style="width:73.08%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:-0.9pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit No</font>.</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Description</font></p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:36pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.1*</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Opinion of Arnall Golden Gregory LLP regarding legality</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.1</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consent of Arnall Golden Gregory LLP (included in Exhibit 5.1)</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.2*</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consent of Haskell &amp; White LLP</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr style="height:3pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.3*</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consent of Deloitte &amp; Touche LLP</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:3.08%;width:96.15%;">
<tr>
<td style="width:23.08%;"></td>
<td style="width:73.08%;"></td>
</tr>
<tr style="height:3pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.4*</font></p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consent of WithumSmith+Brown, PC</p></td>
</tr>
<tr style="height:3pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Power of Attorney (included on signature page)</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1*</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Catheter Precision, Inc. Amended and Restated 2009 Equity Incentive Plan </p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.2*</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Catheter Precision, Inc. Notice of Non-Plan Stock Option Award Agreement and Stock Option Award Terms  </p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107*</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Filing Fee Table</p></td>
</tr>
</table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:76.92%;">
<tr>
<td valign="top" style="width:30.77%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">__________________</p></td>
<td valign="top" style="width:23.08%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:30.77%;margin-right:23.08%;text-indent:-30.77%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:30.77%;margin-right:23.08%;text-indent:-30.77%;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* Filed herewith.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Item 9.  Undertakings</font>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">(a)<font style="margin-left:36pt;">The undersigned Registrant hereby undertakes as follows:</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:23.08%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">(1)To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:23.08%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(</font><font style="font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">To include any prospectus required by Section 10(a)(3) of the Securities Act;</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:23.08%;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:23.08%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement; and</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:23.08%;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:23.08%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)</font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement.</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:15.38%;text-indent:0%;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provided, however, that paragraphs (1)(i) and (1)(ii) shall not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the SEC by the Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Registration Statement.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:23.08%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">(2)That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:23.08%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">(3)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:15.38%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">(b)The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the </p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:11.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:15.38%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><font style="font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:15.38%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">(c)Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.&nbsp;&nbsp;In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p></td></tr></table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="Sigatures"></a><font style="text-decoration:underline;"><br /></font></p>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:11.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;"><a name="Sigatures"></a>SIGN</font><font style="text-decoration:underline;">ATURES</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Carlsbad, State of California, on <font style="font-family:CG Times;">February 2, 2023</font>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:36.72%;"></td>
<td style="width:63.28%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RA MEDICAL SYSTEMS, INC.</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:<font style="text-decoration:underline;">/s/ Jonathan Will McGuire</font></p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jonathan Will McGuire</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the date indicated.&nbsp;&nbsp;Each person whose signature appears below hereby constitutes and appoints Jonathan Will McGuire and David A. Jenkins, and each of them individually, as such person&#8217;s true and lawful attorney&#8209;in&#8209;fact and agent with full power of substitution for such person and in such person&#8217;s name, place and stead, in any and all capacities, to sign and to file with the Securities and Exchange Commission, any and all amendments and post-effective amendments to this Registration Statement, with exhibits thereto and other documents in connection therewith, granting unto said attorneys&#8209;in&#8209;fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorneys&#8209;in&#8209;fact and agents, or any substitute therefor, may lawfully do or cause to be done by virtue thereof.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:1.28%;width:508.5pt;;">
<tr>
<td style="width:166.5pt;"></td>
<td style="width:229.5pt;"></td>
<td style="width:112.5pt;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:2pt;margin-top:4pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">SIGNATURE</font></p></td>
<td valign="top" >
<p style="margin-bottom:2pt;margin-top:4pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">TITLE</font></p></td>
<td valign="top" >
<p style="margin-bottom:2pt;margin-top:4pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">DATE</font></p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-top:4pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:2pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">/s/ Jonathan Will McGuire</font></p>
<p style="margin-bottom:2pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jonathan Will McGuire</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director and Chief Executive Officer<font style="letter-spacing:-0.15pt;color:#000000;"> (Principal Executive Officer)</font></p></td>
<td valign="top" >
<p style="margin-bottom:2pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:2pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:CG Times;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 2, 2023</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:2pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:2pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">/s/ Brian Conn</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Brian Conn</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interim Chief Financial Officer </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Principal Financial and Accounting Officer)</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:CG Times;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 3, 2023</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">/s/ David A. Jenkins&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David A. Jenkins</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Executive Chairman of the Board of Directors</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:CG Times;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 6, 2023</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">/s/ James J. Caruso&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">James J. Caruso</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:CG Times;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 6, 2023</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">/s/ Martin Colombatto</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Martin Colombatto </p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:CG Times;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 2, 2023</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">/s/ Susanne Meline</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Susanne Meline</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:CG Times;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 6, 2023</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:11.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT INDEX</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:3.08%;width:96.15%;">
<tr>
<td style="width:23.08%;"></td>
<td style="width:73.08%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:-0.9pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit No</font>.</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Description</font></p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:36pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.1*</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="rmed-ex51_10.htm"><font style="text-decoration:underline;">Opinion of Arnall Golden Gregory LLP regarding legality.</font></a></p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.1</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="rmed-ex51_10.htm"><font style="text-decoration:underline;">Consent of Arnall Golden Gregory LLP (included in Exhibit 5.1).</font></a></p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.2*</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="rmed-ex232_8.htm"><font style="text-decoration:underline;">Consent of Haskell &amp; White LLP.</font></a></p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr style="height:3pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.3*</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="rmed-ex233_9.htm"><font style="text-decoration:underline;">Consent of Deloitte &amp; Touche LLP.</font></a></p></td>
</tr>
<tr style="height:3pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.4*</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="rmed-ex234_7.htm"><font style="text-decoration:underline;">Consent of WithumSmith+Brown, PC.</font></a></p></td>
</tr>
<tr style="height:3pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#Sigatures"><font style="text-decoration:underline;">Power of Attorney (included on signature page).</font></a></p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1*</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="rmed-ex991_31.htm"><font style="text-decoration:underline;">Catheter Precision, Inc. Amended and Restated 2009 Equity Incentive Plan.</font></a><font style="font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.2*</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="rmed-ex992_30.htm"><font style="text-decoration:underline;">Catheter Precision, Inc. Notice of Non-Plan Stock Option Award Agreement and Stock Option Award Terms.</font></a><font style="font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107*</p></td>
<td valign="top" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="rmed-exfilingfees_6.htm"><font style="text-decoration:underline;">Filing Fee Table.</font></a></p></td>
</tr>
</table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:76.92%;">
<tr>
<td valign="top" style="width:30.77%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">__________________</p></td>
<td valign="top" style="width:23.08%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:30.77%;margin-right:23.08%;text-indent:-30.77%;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:30.77%;margin-right:23.08%;text-indent:-30.77%;font-size:11pt;letter-spacing:-0.15pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* Filed herewith.</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-right:3.85%;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:11.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</a></p></body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "rmed-s8.htm", "description": "S-8", "secsgml_size_bytes": 136608}]
{"company-data": {"conformed-name": "Ra Medical Systems, Inc.", "cik": "0001716621", "assigned-sic": "3841", "irs-number": "383661826", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-269612", "film-number": "23592589"}, "business-address": {"street1": "5857 OWENS DRIVE, SUITE 300", "city": "CARLSBAD", "state": "CA", "zip": "92009", "phone": "(760) 804-1648"}, "mail-address": {"street1": "5857 OWENS DRIVE, SUITE 300", "city": "CARLSBAD", "state": "CA", "zip": "92009"}}
rmed-s8.htm
As filed with the Securities and Exchange Commission on February 7, 2023
Registration Statement No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
RA MEDICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
Delaware
38-3661826
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1670 Highway 160 West, Suite 205
Fort Mill, SC 29708
(Address of Principal Executive Offices) (Zip Code)
Stock Options Granted under the
Catheter Precision, Inc. Amended and Restated 2009 Equity Incentive Plan
and
Notice of Non-Plan Stock Option Award and Stock Option Award Terms
(Full title of the plan)
Jonathan Will McGuire
Chief Executive Officer
Ra Medical Systems Inc.
1670 Highway 160 West, Suite 205
Fort Mill, SC 29708
(973) 691-2000
(Name and address of agent for service) (Telephone number, including area code, of agent for service)
Copies to:
B. Joseph Alley, Jr., Esq.
Arnall Golden Gregory LLP
171 17
th
Street NW, Suite 2100
Atlanta, Georgia 30363
(404) 873-8500
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☐
Accelerated filer
☐
Non-accelerated filer
☒
Smaller reporting company
☒
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
☐
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The information specified in Items 1 and 2 of Part I of Form S-8 is omitted from this Registration Statement on Form S-8 (the "Registration Statement") in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the "Securities Act"), and the introductory note to Part I of Form S-8. The documents containing the information specified in Part I of Form S-8 will be sent or given to the holders of stock options to purchase up to 753,699 shares of Ra Medical Systems, Inc. common stock granted under the Catheter Precision, Inc. Amended and Restated 2009 Equity Incentive Plan (the "Plan") and a Notice of Non-Plan Stock Option Award and Stock Option Award Terms that have been assumed by Ra Medical Systems, Inc. in connection with its acquisition by merger of Catheter Precision, Inc., and that are covered by this Registration Statement, as required by Rule 428(b)(1) under the Securities Act. Such documents are not required to be, and are not, filed with the Securities and Exchange Commission (the "SEC") either as part of this Registration Statement or as a prospectus or prospectus supplement pursuant to Rule 424 under the Securities Act.
PART II
Item 3.
Incorporation of Documents by Reference
.
The following documents filed with the SEC by Ra Medical Systems, Inc. (the "Registrant" or the "Company") are hereby incorporated by reference herein:
a)
our Annual Report on Form 10-K (excluding Item 15) for the year ended December 31, 2021, filed with the SEC on March 24, 2022
;
b)
our Annual Report on Form 10-K/A for the year ended December 31, 2021, filed with the SEC on July 13, 2022
;
c)
the information specifically incorporated by reference in our Annual Report on Form 10-K for the year ended December 31, 2021, from our Definitive Proxy Statement related to our 2022 Annual Meeting of Stockholders, filed with the SEC on
April 21, 2022
;
d)
our Quarterly Reports on Form 10-Q for the quarterly period ended March 31, 2022, filed with the SEC on
May 16, 2022
; for the quarterly period ended June 30, 2022, filed with the SEC on
August 15, 2022
; and for the quarterly period ended September 30, 2022, filed with the SEC on
November 14, 2022
;
e)
our Current Reports on Form 8-K and amendments thereto filed with the SEC on
January 24, 2022
,
February 9, 2022
,
April 20, 2022
,
May 16, 2022
(excluding information furnished thereunder),
June 6, 2022
,
July 8, 2022
(excluding information furnished thereunder),
July 18, 2022
,
July 22, 2022
, as amended on
September 2, 2022
,
August 12, 2022
,
August 17, 2022
,
September 2, 2022
,
September 12, 2022
,
September 20, 2022
,
September 27, 2022
,
September 29, 2022
,
October 4, 2022
,
October 17, 2022
,
October 20, 2022
,
November 3, 2022
,
November 29, 2022
,
December 2, 2022
,
December 15, 2022
, and
January 13, 2023
, as amended
January 19, 2023
; and
f)
our Definitive Proxy Statement related to our September 20, 2022 Special Meeting of Stockholders, filed with the SEC on
August 29, 2022
;
g)
our revised Preliminary Proxy Statement filed with the SEC on
November 4, 2022
; and
2
h)
the description of our common stock contained in our Registration Statement on Form 8-A that we filed with the SEC on
December 17, 2020
, including any amendment or report filed for the purpose of updating such description.
All documents that we file with the SEC pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), after the filing of this Registration Statement on Form S‑8 (and prior to the filing of any post‑effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which de-registers all securities remaining unsold), shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of such reports and documents.
Any statement contained in this Registration Statement, in an amendment hereto or in a document incorporated by reference herein shall be deemed modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein, in any subsequently filed supplement to this Registration Statement or any document that is also incorporated by reference herein modifies or supersedes such statement.  Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 4.
Description of Securities
.
Not applicable.
Item 5.  Interests of Named Experts and Counsel.
Not applicable.
Item 6.  Indemnification of Directors and Officers
.
Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that eliminate the personal liability of our directors and executive officers for monetary damages for breach of their fiduciary duties as directors or officers.
Section 145 of the Delaware General Corporation Law provides that a corporation may indemnify any person made a party to an action by reason of the fact that he or she was a director, executive officer, employee or agent of the corporation or is or was serving at the request of a corporation against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of an action by or in right of the corporation, no indemnification may generally be made in respect of any claim as to which such person is adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.
In addition, as permitted by Section 145 of the Delaware General Corporation Law, our amended and restated certificate of incorporation and amended and restated bylaws will provide that:
We shall indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Delaware law. Delaware law provides
3
that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of us and, with respect to any criminal proceeding, had no reasonable cause to believe such person's conduct was unlawful.
We may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law.
We are required to advance expenses, as incurred, to its directors and officers in connection with defending a proceeding, except that such director or officer shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification.
We will not be obligated pursuant to the amended and restated bylaws to indemnify a person with respect to proceedings initiated by that person, except with respect to proceedings authorized by our board of directors or brought to enforce a right to indemnification.
The rights conferred in the amended and restated certificate of incorporation and amended and restated bylaws are not exclusive, and we are authorized to enter into indemnification agreements with its directors, officers, employees, and agents and to obtain insurance to indemnify such persons.
We may not retroactively amend the bylaw provisions to reduce our indemnification obligations to directors, officers, employees, and agents.
We have entered into indemnification agreements with our directors and executive officers that provide the maximum indemnity allowed to directors and executive officers by Section 145 of the Delaware General Corporation Law and also to provide for certain additional procedural protections, in addition to the indemnification provided for in our amended and restated certificate of incorporation and bylaws.  We also intend to enter into indemnification agreements with any new directors and executive officers in the future.
We have purchased and currently intend to maintain insurance on behalf of each and any person who is or was a director or officer of us against any loss arising from any claim asserted against him or her and incurred by him or her in any such capacity, subject to certain exclusions.
Reference is made to Item 9(c) for our undertakings with respect to indemnification for liabilities arising under the Securities Act.
Item 7.  Exemption from Registration Claimed
.
Not applicable.
Item 8.
Exhibits.
Exhibit No
.
Description
5.1*
Opinion of Arnall Golden Gregory LLP regarding legality
23.1
Consent of Arnall Golden Gregory LLP (included in Exhibit 5.1)
23.2*
Consent of Haskell & White LLP
23.3*
Consent of Deloitte & Touche LLP
4
23.4*
Consent of WithumSmith+Brown, PC
24
Power of Attorney (included on signature page)
99.1*
Catheter Precision, Inc. Amended and Restated 2009 Equity Incentive Plan
99.2*
Catheter Precision, Inc. Notice of Non-Plan Stock Option Award Agreement and Stock Option Award Terms
107*
Filing Fee Table
__________________
* Filed herewith.
Item 9.  Undertakings
.
(a)
The undersigned Registrant hereby undertakes as follows:
(1)To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(
i
)
To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii)
To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement; and
(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement.
Provided, however, that paragraphs (1)(i) and (1)(ii) shall not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the SEC by the Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Registration Statement.
(2)That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(b)The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the
5
securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c)Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.  In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
6
SIGN
ATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Carlsbad, State of California, on
February 2, 2023
.
RA MEDICAL SYSTEMS, INC.
By:
/s/ Jonathan Will McGuire
Jonathan Will McGuire
Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the date indicated.  Each person whose signature appears below hereby constitutes and appoints Jonathan Will McGuire and David A. Jenkins, and each of them individually, as such person's true and lawful attorney‑in‑fact and agent with full power of substitution for such person and in such person's name, place and stead, in any and all capacities, to sign and to file with the Securities and Exchange Commission, any and all amendments and post-effective amendments to this Registration Statement, with exhibits thereto and other documents in connection therewith, granting unto said attorneys‑in‑fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorneys‑in‑fact and agents, or any substitute therefor, may lawfully do or cause to be done by virtue thereof.
SIGNATURE
TITLE
DATE
/s/ Jonathan Will McGuire
Jonathan Will McGuire
Director and Chief Executive Officer
(Principal Executive Officer)
February 2, 2023
/s/ Brian Conn
Brian Conn
Interim Chief Financial Officer
(Principal Financial and Accounting Officer)
February 3, 2023
/s/ David A. Jenkins
David A. Jenkins
Executive Chairman of the Board of Directors
February 6, 2023
/s/ James J. Caruso
James J. Caruso
Director
February 6, 2023
/s/ Martin Colombatto
Martin Colombatto
Director
February 2, 2023
/s/ Susanne Meline
Susanne Meline
Director
February 6, 2023
7
EXHIBIT INDEX
Exhibit No
.
Description
5.1*
Opinion of Arnall Golden Gregory LLP regarding legality.
23.1
Consent of Arnall Golden Gregory LLP (included in Exhibit 5.1).
23.2*
Consent of Haskell & White LLP.
23.3*
Consent of Deloitte & Touche LLP.
23.4*
Consent of WithumSmith+Brown, PC.
24
Power of Attorney (included on signature page).
99.1*
Catheter Precision, Inc. Amended and Restated 2009 Equity Incentive Plan.
99.2*
Catheter Precision, Inc. Notice of Non-Plan Stock Option Award Agreement and Stock Option Award Terms.
107*
Filing Fee Table.
__________________
* Filed herewith.
8